SEC Filing Analysis: SOPHIA GENETICS SA (SOPH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director filed a notice for a small, pre-planned sale of company stock, representing a negligible fraction of the company's market capitalization and outstanding shares.
• Market Impact: Neutral, as the transaction is minor and was scheduled under a 10b5-1 plan.

Company Information

Field	Value
Company	SOPHIA GENETICS SA
Ticker Symbol	SOPH
CIK	0001840706
Industry	SERVICES-COMPUTER PROCESSING & DATA PREPARATION

Insider Information

Field	Value
Name	KATHY L HIBBS
CIK	0001267487
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-03
Transaction Code	S
Security Type	Common
Shares Involved	10,000
Price Per Share	$5.00
Total Value	$50,000
Shares Owned After	null
Ownership Type	null

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$50,000
% of Market Cap	0.014%
Shares Transacted	10,000
% of Shares Outstanding	0.015%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $50,000 transaction is insignificant against the company's $350 million market capitalization.
• Transaction Significance: The sale represents a very small fraction of both market capitalization (<0.1%) and shares outstanding (<0.1%), categorizing it as a low-significance event.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction's small size and its pre-scheduled nature under a 10b5-1 plan suggest it is part of a routine financial management strategy by the insider, rather than a reaction to new non-public information.

Volume & Sentiment

• Expected Volume Impact: Minimal. The number of shares is too small to materially affect trading volume.
• Sentiment Indicator: Neutral. This type of minor, planned sale is common and typically does not influence market sentiment.

Additional Context

Special Circumstances

• The filing indicates the sale is pursuant to a trading plan adopted on December 5, 2024, which is consistent with a Rule 10b5-1 plan. This allows insiders to pre-schedule trades to avoid accusations of trading on non-public information.